Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Brain Sci ; 13(4)2023 Apr 18.
Article in English | MEDLINE | ID: mdl-37190640

ABSTRACT

Post-COVID-19 syndrome (PCS) fatigue is typically most severe <6 months post-infection. Combining magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging with the glucose analog [18F]-Fluorodeoxyglucose (FDG) provides a comprehensive overview of the effects of PCS on regional brain volumes and metabolism, respectively. The primary purpose of this exploratory study was to investigate differences in MRI/PET outcomes between people < 6 months (N = 18, 11 female) and > 6 months (N = 15, 6 female) after COVID-19. The secondary purpose was to assess if any differences in MRI/PET outcomes were associated with fatigue symptoms. Subjects > 6 months showed smaller volumes in the putamen, pallidum, and thalamus compared to subjects < 6 months. In subjects > 6 months, fatigued subjects had smaller volumes in frontal areas compared to non-fatigued subjects. Moreover, worse fatigue was associated with smaller volumes in several frontal areas in subjects > 6 months. The results revealed no brain metabolism differences between subjects > 6 and < 6 months. However, both groups exhibited both regional hypo- and hypermetabolism compared to a normative database. These results suggest that PCS may alter regional brain volumes but not metabolism in people > 6 months, particularly those experiencing fatigue symptoms.

2.
Front Hum Neurosci ; 16: 833619, 2022.
Article in English | MEDLINE | ID: mdl-35145388

ABSTRACT

Common symptoms of multiple sclerosis (MS) include motor impairments of the lower extremities, particularly gait disturbances. Loss of balance and muscle weakness, representing some peripheral effects, have been shown to influence these symptoms, however, the individual role of cortical and subcortical structures in the central nervous system is still to be understood. Assessing [18F]fluorodeoxyglucose (FDG) uptake in the CNS can assess brain activity and is directly associated with regional neuronal activity. One potential modality to increase cortical excitability and improve motor function in patients with MS (PwMS) is transcranial direct current stimulation (tDCS). However, tDCS group outcomes may not mirror individual subject responses, which impedes our knowledge of the pathophysiology and management of diseases like MS. Three PwMS randomly received both 3 mA tDCS and SHAM targeting the motor cortex (M1) that controls the more-affected leg for 20 min on separate days before walking on a treadmill. The radiotracer, FDG, was injected at minute two of the 20 min walk and the subjects underwent a Positron emission tomography (PET) scan immediately after the task. Differences in relative regional metabolism of areas under the tDCS anode and the basal ganglia were calculated and investigated. The results indicated diverse and individualized responses in regions under the anode and consistent increases in some basal ganglia areas (e.g., caudate nucleus). Thus, anodal tDCS targeting the M1 that controls the more-affected leg of PwMS might be capable of affecting remote subcortical regions and modulating the activity (motor, cognitive, and behavioral functions) of the circuitry connected to these regions.

3.
Neuroradiol J ; 34(4): 263-288, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33666110

ABSTRACT

Neurodegenerative diseases (NDDs) are characterized by progressive neuronal loss, leading to dementia and movement disorders. NDDs broadly include Alzheimer's disease, frontotemporal lobar degeneration, parkinsonian syndromes, and prion diseases. There is an ever-increasing prevalence of mild cognitive impairment and dementia, with an accompanying immense economic impact, prompting efforts aimed at early identification and effective interventions. Neuroimaging is an essential tool for the early diagnosis of NDDs in both clinical and research settings. Structural, functional, and metabolic imaging modalities, including magnetic resonance imaging (MRI) and positron emission tomography (PET), are widely available. They show encouraging results for diagnosis, monitoring, and treatment response evaluation. The current review focuses on the complementary role of various imaging modalities in relation to NDDs, the qualitative and quantitative utility of newer MRI techniques, novel radiopharmaceuticals, and integrated PET/MRI in the setting of NDDs.


Subject(s)
Multiparametric Magnetic Resonance Imaging , Neurodegenerative Diseases , Humans , Magnetic Resonance Imaging , Neurodegenerative Diseases/diagnostic imaging , Neuroimaging , Positron-Emission Tomography
4.
J Neuropsychiatry Clin Neurosci ; 32(4): 352-361, 2020.
Article in English | MEDLINE | ID: mdl-32283991

ABSTRACT

OBJECTIVE: The pathological cascades associated with the development of Alzheimer's disease (AD) have a common element: acidosis. T1rho MRI is a pH-sensitive measure, with higher values associated with greater neuropathological burden. The authors investigated the relationship between T1rho imaging and AD-associated pathologies as determined by available diagnostic imaging techniques. METHODS: Twenty-seven participants (men, N=13, women, N=14; ages 55-90) across the cognitive spectrum (healthy control subjects [HCs] with normal cognition, N=17; participants with mild cognitive impairment [MCI], N=7; participants with mild AD, N=3) underwent neuropsychological testing, MRI (T1-weighted and T1rho [spin-lattice relaxation time in the rotating frame]), and positron emission tomography imaging ([11C]Pittsburg compound B for amyloid burden [N=26] and [18F]fluorodeoxyglucose for cerebral glucose metabolism [N=12]). The relationships between global T1rho values and neuropsychological, demographic, and imaging measures were explored. RESULTS: Global mean and median T1rho were positively associated with age. After controlling for age, higher global T1rho was associated with poorer cognitive function, poorer memory function (immediate and delayed memory scores), higher amyloid burden, and more abnormal cerebral glucose metabolism. Regional T1rho values, when controlling for age, significantly differed between HCs and participants with MCI or AD in select frontal, cingulate, and parietal regions. CONCLUSIONS: Higher T1rho values were associated with greater cognitive impairment and pathological burden. T1rho, a biomarker that varies according to a feature common to each cascade rather than one that is unique to a particular pathology, has the potential to serve as a metric of neuropathology, theoretically providing a measure for assessing pathological status and for monitoring the neurodegeneration trajectory.


Subject(s)
Aging , Alzheimer Disease , Amyloid beta-Peptides/metabolism , Cognitive Dysfunction , Glucose/metabolism , Magnetic Resonance Imaging/standards , Neuroimaging/standards , Positron-Emission Tomography/standards , Aged , Aged, 80 and over , Aging/metabolism , Aging/pathology , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Aniline Compounds , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/pathology , Cognitive Dysfunction/physiopathology , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Pilot Projects , Thiazoles
5.
Appl Physiol Nutr Metab ; 45(4): 450-452, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31841355

ABSTRACT

This exploratory pilot study investigated the effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on cerebral glucose metabolism in people with multiple sclerosis (PwMS). Compared with nonusers, THC users had hypermetabolism of 3 regions (p < 0.039, d >1.17) in left temporal areas, while CBD users had hypometabolism of 5 regions (p < 0.032, d > 1.31) in left temporal areas. This study highlights the need to discriminate between THC and CBD in future cannabis studies. Novelty Chronic THC and CBD use had disparate effects on cerebral glucose metabolism in PwMS.


Subject(s)
Cerebral Cortex/metabolism , Dronabinol/pharmacology , Glucose/metabolism , Adult , Aged , Cannabidiol/pharmacology , Dronabinol/administration & dosage , Female , Humans , Male , Middle Aged , Multiple Sclerosis , Pilot Projects
6.
Tomography ; 5(1): 161-169, 2019 03.
Article in English | MEDLINE | ID: mdl-30854454

ABSTRACT

Radiomics is an image analysis approach for extracting large amounts of quantitative information from medical images using a variety of computational methods. Our goal was to evaluate the utility of radiomic feature analysis from 18F-fluorothymidine positron emission tomography (FLT PET) obtained at baseline in prediction of treatment response in patients with head and neck cancer. Thirty patients with advanced-stage oropharyngeal or laryngeal cancer, treated with definitive chemoradiation therapy, underwent FLT PET imaging before treatment. In total, 377 radiomic features of FLT uptake and feature variants were extracted from volumes of interest; these features variants were defined by either the primary tumor or the total lesion burden, which consisted of the primary tumor and all FLT-avid nodes. Feature variants included normalized measurements of uptake, which were calculated by dividing lesion uptake values by the mean uptake value in the bone marrow. Feature reduction was performed using clustering to remove redundancy, leaving 172 representative features. Effects of these features on progression-free survival were modeled with Cox regression and P-values corrected for multiple comparisons. In total, 9 features were considered significant. Our results suggest that smaller, more homogenous lesions at baseline were associated with better prognosis. In addition, features extracted from total lesion burden had a higher concordance index than primary tumor features for 8 of the 9 significant features. Furthermore, total lesion burden features showed lower interobserver variability.


Subject(s)
Head and Neck Neoplasms/diagnostic imaging , Head and Neck Neoplasms/therapy , Squamous Cell Carcinoma of Head and Neck/diagnostic imaging , Squamous Cell Carcinoma of Head and Neck/therapy , Adult , Aged , Chemoradiotherapy/methods , Dideoxynucleosides , Female , Head and Neck Neoplasms/pathology , Humans , Image Interpretation, Computer-Assisted/methods , Male , Middle Aged , Neoplasm Staging , Observer Variation , Positron-Emission Tomography/methods , Prognosis , Prospective Studies , Radiopharmaceuticals , Squamous Cell Carcinoma of Head and Neck/pathology , Treatment Outcome
7.
Hypertension ; 72(2): 476-482, 2018 08.
Article in English | MEDLINE | ID: mdl-29915015

ABSTRACT

Greater aortic stiffness and pulse pressure are associated with cerebrovascular remodeling, reduced white matter microstructure, and cognitive performance with aging in humans. However, it is unclear whether aortic stiffness and pulse pressure are associated with reduced basal global cerebral blood flow (CBF) and cerebrovascular reserve among older adults. Global CBF was quantified in 205 adults (range, 19-87 years; mean±SE: 30.6±1.3 years) using quantitative [15O]water brain positron emission tomography imaging. In a subset of older adults (n=24; 70.0±2.0 years), aortic stiffness (carotid femoral pulse wave velocity) and cerebrovascular reserve (change in global CBF after intravenous infusion of acetazolamide) were assessed. In the entire cohort, global CBF was lower in older compared with young adults (36.5±1.1 versus 50.5±0.7 mL/min per 100 mL; P<0.001). Global CBF was higher in young women compared with young men (51.0±0.30 versus 47.4±0.03 mL/min per 100 mL; P<0.001) but did not differ between older women and men (P=0.63). In older adults, greater carotid femoral pulse wave velocity was associated with lower cerebrovascular reserve (r=-0.68; P=0.001 adjusted for age, sex, and mean arterial pressure) but not global CBF (r=0.13; P=0.60). Brachial pulse pressure was not associated with lower cerebrovascular reserve (r=-0.37; P=0.159) when adjusted for age and sex. These data indicate that the age-related increases in aortic stiffness may contribute, in part, to the brain's impaired ability to augment blood flow in response to a stimulus with aging in humans.


Subject(s)
Aging/physiology , Aorta, Thoracic/physiopathology , Blood Flow Velocity/physiology , Cerebrovascular Circulation/physiology , Cognition/physiology , Vascular Stiffness/physiology , White Matter/blood supply , Adult , Age Factors , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Positron-Emission Tomography , Pulse Wave Analysis , Retrospective Studies , White Matter/diagnostic imaging , Young Adult
8.
Epilepsy Behav ; 78: 62-67, 2018 01.
Article in English | MEDLINE | ID: mdl-29175222

ABSTRACT

OBJECTIVE: The objective of this study was to determine whether preoperative [18F]fludeoxyglucose (FDG)-positron emission tomography (PET) asymmetry in temporal lobe metabolism predicts neuropsychological and seizure outcomes after temporal lobectomy (TL). METHODS: An archival sample of 47 adults with unilateral temporal lobe epilepsy who underwent TL of their language-dominant (29 left, 1 right) or nondominant (17 right) hemisphere were administered neuropsychological measures pre- and postoperatively. Post-TL seizure outcomes were measured at 1year. Regional FDG uptake values were defined by an automated technique, and a quantitative asymmetry index (AI) was calculated to represent the relative difference in the FDG uptake in the epileptic relative to the nonepileptic temporal lobe for four regions of interest: medial anterior temporal (MAT), lateral anterior temporal (LAT), medial posterior temporal (MPT), and lateral posterior temporal (LPT) cortices. RESULTS: In language-dominant TL, naming outcomes were predicted by FDG uptake asymmetry in the MAT (r=-0.38) and LPT (r=-0.45) regions. For all patients, visual search and motor speed outcomes were predicted by FDG uptake asymmetry in all temporal regions (MPT, r=0.42; MAT, r=0.34; LPT, r=0.47; LAT, r=0.51). Seizure outcomes were predicted by FDG uptake asymmetry in the MAT (r=0.36) and MPT (r=0.30) regions. In all of these significant associations, greater hypometabolism in regions of the epileptic temporal lobe was associated with better postoperative outcomes. CONCLUSIONS: Our results support the conclusion that FDG uptake asymmetry is a useful clinical tool in assessing risk for cognitive changes in patients being considered for TL.


Subject(s)
Anterior Temporal Lobectomy/methods , Epilepsy, Temporal Lobe/diagnostic imaging , Memory/physiology , Positron-Emission Tomography/methods , Seizures/surgery , Temporal Lobe/metabolism , Temporal Lobe/surgery , Adult , Epilepsy, Temporal Lobe/surgery , Female , Fluorodeoxyglucose F18/metabolism , Humans , Male , Middle Aged , Neuropsychological Tests , Postoperative Period , Temporal Lobe/diagnostic imaging , Temporal Lobe/physiopathology , Treatment Outcome
9.
J Pharm Sci ; 107(2): 745-755, 2018 02.
Article in English | MEDLINE | ID: mdl-28942005

ABSTRACT

The medical use of marijuana is increasing, yet little is known about the exposure-response relationship for its psychoactive effects. It is well known that the plasma concentrations of the principal psychoactive component of marijuana, Δ9-tetrahydrocannabinol (THC), do not directly correlate to the observed psychoactive effects. The purpose of this research was to use an effect-compartment modeling approach to predict and relate the concentrations of the psychoactive components (THC and its active metabolite) in the "hypothetical" effect-site compartment to the observed psychoactive effects. A "hypothetical" effect-compartment model was developed using literature data to characterize the observed delay in peak "highness" ratings compared with plasma concentrations of the psychoactive agents following intravenous administration of THC. A direct relationship was established between the reported psychoactive effects ("highness" or intoxication) and the predicted effect-site concentrations of THC. The differences between estimated equilibration half-lives for THC and THC-OH in the effect-compartment model indicated the differential equilibration of parent drug and the active metabolite between plasma and the effect-site. These models contribute to the understanding of the pharmacokinetic-pharmacodynamic relationships associated with marijuana use and are important steps in the prediction of pharmacodynamic effects related to the psychoactive components in marijuana.


Subject(s)
Dronabinol/analogs & derivatives , Plasma/metabolism , Psychotropic Drugs/adverse effects , Psychotropic Drugs/blood , Administration, Intravenous/methods , Adolescent , Adult , Cannabis/adverse effects , Dronabinol/adverse effects , Dronabinol/blood , Dronabinol/metabolism , Female , Half-Life , Humans , Male , Marijuana Smoking/adverse effects , Marijuana Smoking/blood , Marijuana Smoking/metabolism , Middle Aged , Psychotropic Drugs/metabolism , Young Adult
10.
J Clin Exp Neuropsychol ; 34(2): 220-5, 2012.
Article in English | MEDLINE | ID: mdl-22149630

ABSTRACT

This study was designed to determine the relationships between positron emission tomography (PET)-based quantitative measures of cerebral blood flow and cerebrovascular reserve and neuropsychological functioning in elderly individuals with atherosclerotic vascular disease. It was hypothesized that cerebrovascular function would be significantly associated with neuropsychological functioning. Results showed that both baseline global cerebral blood flow and cerebrovascular reserve were significantly associated with global neuropsychological functioning, when controlling for age and sex. Cerebrovascular reserve was additionally associated with performance on measures of memory and attention. Additional research is needed to determine whether measures of cerebral blood flow can be used to predict cognitive decline.


Subject(s)
Cerebral Cortex/blood supply , Cerebral Cortex/diagnostic imaging , Cerebrovascular Circulation , Cognition Disorders/pathology , Neuropsychological Tests , Vascular Diseases/pathology , Aged , Cognition Disorders/etiology , Female , Humans , Male , Middle Aged , Positron-Emission Tomography , Vascular Diseases/complications
11.
Int J Radiat Oncol Biol Phys ; 81(3): 888-93, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21300484

ABSTRACT

PURPOSE: The purpose of this study was to quantify the relationship of bone marrow response to radiation dose, using 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT)-labeled uptake quantified in positron-emission tomography (PET) scans. METHODS AND MATERIALS: Pre- and post-Week 1 treatment [(18)F]FLT PET images were registered to the CT images used to create the radiation treatment plan. Changes in [(18)F]FLT uptake values were measured using profile data of standardized uptake values (SUVs) and doses along the vertebral bodies located at a field border where a range of radiation doses were present for 10 patients. Data from the profile measurements were grouped into 1 Gy dose bins from 1 to 9 Gy to compare SUV changes for all patients. Additionally, the maximum pretreatment, the post-Week 1 treatment, and the dose values located within the C6-T7 vertebrae that straddled the field edge were measured for all patients. RESULTS: Both the profile and the individual vertebral data showed a strong correlation between SUV change and radiation dose. Relative differences in SUVs between bins >1 Gy and <7 Gy were statistically significant (p < 0.01, two-sample t test). The reduction in SUV was approximately linear until it reached a reduction threshold of 75%-80% in SUV for doses greater than 6 Gy/week for both the dose-binned data and the vertebral maximum SUVs. CONCLUSIONS: The change in SUV observed in head and neck cancer patients treated with chemoradiation shows the potential for using [(18)F]FLT PET images for identifying active bone marrow and monitoring changes due to radiation dose. Additionally, the change in [(18)F]FLT uptake observed in bone marrow for different weekly doses suggests potential dose thresholds for reducing bone marrow toxicity.


Subject(s)
Bone Marrow/diagnostic imaging , Bone Marrow/radiation effects , Dideoxynucleosides , Fluorine Radioisotopes , Head and Neck Neoplasms/radiotherapy , Positron-Emission Tomography/methods , Bone Marrow Cells/cytology , Bone Marrow Cells/diagnostic imaging , Bone Marrow Cells/radiation effects , Cell Proliferation/radiation effects , Dose-Response Relationship, Radiation , Humans , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Tomography, X-Ray Computed
12.
J Stroke Cerebrovasc Dis ; 20(2): 94-104, 2011.
Article in English | MEDLINE | ID: mdl-20656512

ABSTRACT

Stroke of the right MCA is common. Such strokes often have consequences for emotional experience, but these can be subtle. In such cases diagnosis is difficult because emotional awareness (limiting reporting of emotional changes) may be affected. The present study sought to clarify the mechanisms of altered emotion experience after right MCA stroke. It was predicted that after right MCA stroke the anterior cingulate cortex (ACC), a brain region concerned with emotional awareness, would show reduced neural activity. Brain activity during presentation of emotional stimuli was measured in 6 patients with stable stroke, and in 12 age- and sex-matched nonlesion comparisons using positron emission tomography and the [(15)O]H(2)O autoradiographic method. MCA stroke was associated with weaker pleasant experience and decreased activity ipsilaterally in the ACC. Other regions involved in emotional processing including thalamus, dorsal and medial prefrontal cortex showed reduced activity ipsilaterally. Dorsal and medial prefrontal cortex, association visual cortex and cerebellum showed reduced activity contralaterally. Experience from unpleasant stimuli was unaltered and was associated with decreased activity only in the left midbrain. Right MCA stroke may reduce experience of pleasant emotions by altering brain activity in limbic and paralimbic regions distant from the area of direct damage, in addition to changes due to direct tissue damage to insula and basal ganglia. The knowledge acquired in this study begins to explain the mechanisms underlying emotional changes following right MCA stroke. Recognizing these changes may improve diagnoses, management and rehabilitation of right MCA stroke victims.


Subject(s)
Affective Symptoms/etiology , Emotions , Infarction, Middle Cerebral Artery/complications , Limbic System/physiopathology , Affective Symptoms/diagnosis , Affective Symptoms/physiopathology , Affective Symptoms/psychology , Aged , Autoradiography , Awareness , Brain Mapping/methods , Case-Control Studies , Cognition , Female , Humans , Infarction, Middle Cerebral Artery/diagnosis , Infarction, Middle Cerebral Artery/physiopathology , Infarction, Middle Cerebral Artery/psychology , Limbic System/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Neural Pathways/physiopathology , Neuropsychological Tests , Positron-Emission Tomography , Psychiatric Status Rating Scales , Radiography
13.
Cancer Biother Radiopharm ; 25(3): 361-3, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20578842

ABSTRACT

The purpose of this study was to evaluate the consistency of 3'-deoxy-3'[(18)F]fluorothymidine (FLT) standardized uptake values (SUVs) over the time course of imaging in head and neck cancer. Thirteen (13) subjects (all male; age: 56.9 +/- 6.7 years) with squamous cell head and neck cancer, stage III/IV, were administered FLT and imaged dynamically for 1 hour over the tumor and then underwent whole-body (WB) imaging commencing at 74 +/- 6 minutes. Imaging was repeated after 5 days of radiotherapy (10 Gy) and a single course of platinum-based chemotherapy. Volumes-of-interest (VOIs) were created on the last dynamic frame (SUV(60)). The pretherapy WB and midtherapy images were coregistered to the dynamic sequence and VOIs were applied. Mean and maximum SUVs (SUV(60) and SUV(WB)) and the change with treatment were evaluated. The correlations (Spearman's rho) between SUV(60) and SUV(WB) for all VOIs (pre- and midtherapy, n = 108 data pairs) were 0.98 for mean and 0.97 for maximum SUVs (p < 0.0001). Average absolute differences between SUV(60) and SUV(WB) were 0.18 +/- 0.15 and 0.29 +/- 0.32 SUV units, respectively. Correlations (Spearman's rho) between the change in SUV with therapy were 0.90 for mean and 0.89 for maximum SUV (p < 0.0001), with differences in the change values averaging 0.03 +/- 0.36 and -0.17 +/- 0.57 units, respectively. FLT SUVs are stable and comparable for images initiated between 55 and 100 minutes postinjection whether acquired pre- or midtherapy in head and neck cancer.


Subject(s)
Dideoxynucleosides/pharmacokinetics , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/metabolism , Positron-Emission Tomography , Radiopharmaceuticals/pharmacokinetics , Aged , Carboplatin/therapeutic use , Cisplatin/therapeutic use , Dideoxynucleosides/administration & dosage , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Humans , Male , Middle Aged , Paclitaxel/therapeutic use , Radiopharmaceuticals/administration & dosage , Time Factors
14.
J Nucl Med ; 50(7): 1028-35, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19525472

ABSTRACT

UNLABELLED: The purpose of this study was to investigate the kinetic behavior of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) before and early after initiation of chemoradiation therapy in patients with squamous cell head and neck cancer. METHODS: A total of 8 patients with head and neck cancer underwent (18)F-FLT PET scans (7 patients at baseline and after 5 d [10 Gy] of radiation therapy given with concomitant chemotherapy and 1 patient only at baseline). Dynamic PET images were obtained with concurrent arterial or venous blood sampling. Kinetic parameters including the flux constant of (18)F-FLT based on compartmental analysis (K-FLT), the Patlak influx constant (K-Patlak), and standardized uptake value (SUV) were calculated for the primary tumor and (18)F-FLT-avid cervical lymph nodes for all scans. RESULTS: Mean pretreatment values of uptake for the primary tumor and cervical nodes were 0.075 +/- 0.006 min(-1), 0.042 +/- 0.004 min(-1), and 3.4 +/- 0.5 (mean +/- SD) for K-FLT, K-Patlak, and SUV, respectively. After 10 Gy of radiation therapy, these values were 0.040 +/- 0.01 min(-1), 0.018 +/- 0.016 min(-1), and 1.8 +/- 1.1 for K-FLT, K-Patlak, and SUV, respectively. For all lesions seen on pretherapy and midtherapy scans, the correlation was 0.90 between K-FLT and K-Patlak, 0.91 between K-FLT and SUV, and 0.99 between K-Patlak and SUV. CONCLUSION: The initial (18)F-FLT uptake and change early after treatment in squamous head and neck tumors can be adequately characterized with SUV obtained at 45-60 min, which demonstrates excellent correlation with influx parameters obtained from compartmental and Patlak analyses.


Subject(s)
Dideoxynucleosides/pharmacokinetics , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/therapy , Models, Biological , Radiopharmaceuticals/pharmacokinetics , Adult , Chemotherapy, Adjuvant , Combined Modality Therapy , Computer Simulation , Female , Head and Neck Neoplasms/diagnostic imaging , Humans , Kinetics , Male , Metabolic Clearance Rate , Middle Aged , Radionuclide Imaging , Radiotherapy, Adjuvant
15.
J ECT ; 23(4): 265-73, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18090701

ABSTRACT

OBJECTIVES: Although electroconvulsive therapy (ECT) is a very effective treatment of depression and psychosis, the mechanisms by which this occurs are not fully delineated. The objective of this study was to investigate the functional alterations in brain metabolism in response to ECT through the use of positron emission tomography assessment of cerebral glucose metabolism before and after a course of ECT. METHODS: Ten subjects with psychotic depression were studied with positron emission tomography using [F]fluorodeoxyglucose before and between 2 and 3 weeks after a course of ECT. Statistical parametric mapping and region of interest analyses of the anterior cingulate cortex (ACC) subregions (dorsal, rostral, subcallosal, and subgenual) and hippocampus were used to determine glucose metabolic changes from ECT. The Hamilton Depression Rating Scale and the Scale for Assessing Positive Symptoms were the primary measures used for assessing clinical changes from ECT. RESULTS: Electroconvulsive therapy led to significant increases in the left subgenual ACC and hippocampal metabolism, which were directly correlated with each other and to a reduction in depression as measured by total Hamilton Depression Rating Scale scores. Better antidepressant responders had increased, whereas poorer responders had a decreased left subgenual ACC and hippocampal metabolism. The decrease in positive symptoms was also correlated with increased left hippocampal metabolism. CONCLUSIONS: The antidepressant effect of ECT was correlated with increased metabolism in the left subgenual ACC and hippocampus, whereas the antipsychotic effect of ECT was only correlated with increased left hippocampal metabolism. This finding has implications to better understand the mechanism of antidepressant and antipsychotic effects of ECT.


Subject(s)
Brain/physiopathology , Depressive Disorder, Major/therapy , Electroconvulsive Therapy , Energy Metabolism/physiology , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Positron-Emission Tomography , Adult , Affect/drug effects , Affect/physiology , Antidepressive Agents/administration & dosage , Antipsychotic Agents/administration & dosage , Brain/diagnostic imaging , Brain/drug effects , Brain Mapping , Combined Modality Therapy , Corpus Callosum/diagnostic imaging , Corpus Callosum/drug effects , Corpus Callosum/physiopathology , Depressive Disorder, Major/diagnostic imaging , Depressive Disorder, Major/physiopathology , Dominance, Cerebral/physiology , Energy Metabolism/drug effects , Female , Fluorodeoxyglucose F18 , Gyrus Cinguli/diagnostic imaging , Gyrus Cinguli/drug effects , Gyrus Cinguli/physiopathology , Hippocampus/diagnostic imaging , Hippocampus/drug effects , Hippocampus/physiopathology , Humans , Male , Middle Aged , Neuropsychological Tests , Personality Inventory , Psychiatric Status Rating Scales , Treatment Outcome
16.
Neuroimage ; 37(4): 1346-53, 2007 Oct 01.
Article in English | MEDLINE | ID: mdl-17692536

ABSTRACT

The anterior cingulate cortex (ACC) is thought to be the neuroanatomical interface between emotion and cognition. Because effective emotion-cognition interactions are essential to optimal decision making, clarifying how the functionality of the ACC changes in older age using functional imaging holds great promise for ultimately understanding what contributes to the psychological changes occurring in late life. However, the interpretation of functional imaging studies is complicated by the fact that aging is associated with changes in grey matter volume and in the cerebral vasculature. In the present study, we obtained high-resolution structural magnetic resonance (MR) imaging data and quantitative blood flow images to examine the association between aging, blood flow, and grey matter volume in the ACC. Twenty-six healthy individuals between 25 and 79 years of age underwent quantitative [15O]water positron emission tomography (PET) imaging. The ACC was traced onto tissue-classified images derived from T1- and T2-weighted MRIs using previously defined methods. The ACC was divided into dorsal, rostral, and subgenual regions. Age was negatively correlated with blood flow in dorsal and rostral ACC regions. Effects were weaker but in a similar direction for the subgenual ACC. While older age and lower blood flow were both associated with smaller rostral ACC grey matter volumes, mediation analysis revealed that grey matter volume only partially mediated the effect of age on blood flow in the rostral ACC. Neural alterations not detectable on MR images may lead to reduced blood flow due to fewer and/or less metabolically active neurons. Alternatively, lower blood flow may be a cause, rather than a consequence, of smaller grey matter volume in the ACC.


Subject(s)
Aging/physiology , Cerebral Cortex/growth & development , Cerebral Cortex/physiology , Adult , Aged , Cerebral Cortex/blood supply , Cerebrovascular Circulation/physiology , Data Interpretation, Statistical , Emotions/physiology , Fear/physiology , Female , Happiness , Humans , Image Processing, Computer-Assisted/statistics & numerical data , Magnetic Resonance Imaging , Male , Middle Aged , Neurons/physiology , Photic Stimulation , Positron-Emission Tomography
17.
Am J Psychiatry ; 164(2): 339-41, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17267799

ABSTRACT

OBJECTIVE: Extraversion, a trait associated with individual differences in approach motivation and the experience of positive emotional states, is negatively correlated with certain psychiatric disorders, including depression and social phobia. The authors examined the correlation between extraversion and regional cerebral blood flow (rCBF) while participants were exposed to olfactory stimuli in order to further characterize individual differences in hedonic processing associated with this trait. METHOD: Twelve healthy participants were exposed to pleasant and unpleasant odors while rCBF was measured using [(15)O] water PET. The NEO Five-Factor Inventory was used to assess extraversion. Associations between extraversion scores and rCBF in each olfactory stimulus condition were assessed by correlational analysis. RESULTS: During the pleasant smell condition, extraversion was correlated with rCBF in the amygdala and occipital cortex. During the unpleasant smell condition, extraversion was correlated with rCBF in the occipital cortex and inferior temporal gyrus. CONCLUSIONS: These results provide important evidence for the biological basis of extraversion and indicate that there are systematic individual differences in patterns of brain activation in response to affective stimuli.


Subject(s)
Brain/blood supply , Emotions/physiology , Extraversion, Psychological , Smell/physiology , Adult , Amygdala/blood supply , Amygdala/diagnostic imaging , Brain/diagnostic imaging , Female , Humans , Individuality , Male , Middle Aged , Occipital Lobe/blood supply , Occipital Lobe/diagnostic imaging , Odorants , Oxygen Radioisotopes , Personality Inventory , Physical Stimulation/methods , Positron-Emission Tomography , Regional Blood Flow , Water
18.
Neuropsychologia ; 45(6): 1331-41, 2007 Mar 25.
Article in English | MEDLINE | ID: mdl-17123557

ABSTRACT

While the role of the cerebellum in motor coordination is widely accepted, the notion that it is involved in emotion has only recently gained popularity. To date, functional neuroimaging has not been used in combination with lesion studies to elucidate the role of the cerebellum in the processing of emotional material. We examined six participants with cerebellar stroke and nine age and education matched healthy volunteers. In addition to a complete neuropsychological, neurologic, and psychiatric examination, participants underwent [15O]water positron emission tomography (PET) while responding to emotion-evoking visual stimuli. Cerebellar lesions were associated with reduced pleasant experience in response to happiness-evoking stimuli. Stroke patients reported an unpleasant experience to frightening stimuli similar to healthy controls, yet showed significantly lower activity in the right ventral lateral and left dorsolateral prefrontal cortex, amygdala, thalamus, and retrosplenial cingulate gyrus. Frightening stimuli led to increased activity in the ventral medial prefrontal, anterior cingulate, pulvinar, and insular cortex. This suggests that alternate neural circuitry became responsible for maintaining the evolutionarily critical fear response after cerebellar damage.


Subject(s)
Cerebellum/physiology , Emotions/physiology , Aged , Cerebellar Diseases/diagnostic imaging , Cerebellar Diseases/etiology , Cerebellar Diseases/psychology , Cerebellum/diagnostic imaging , Cerebral Infarction/complications , Cerebral Infarction/psychology , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Photic Stimulation , Positron-Emission Tomography , Psychiatric Status Rating Scales , Social Perception
19.
Mol Imaging Biol ; 8(6): 363-72, 2006.
Article in English | MEDLINE | ID: mdl-17048070

ABSTRACT

PURPOSE: This study was undertaken to explore the mechanisms underlying cognitive reserve in subjects with mild memory deficits by using positron emission tomography (PET). METHODS: Global cerebral blood flow (gCBF) and cerebrovascular reserve (CVR) measurements were performed in 15 elders (5 men, 10 women, 62-84, 71.8 +/- 6.2 years) meeting criteria for mild cognitive impairment (MCI). PET consisted of quantitative [(15)O]water determinations of CBF, two at baseline and one postadministration of acetazolamide (ACZ). RESULTS: Mean gCBF were 44.9 +/- 5.5 during counting, 44.5 +/- 6.7 for the memory task, and 60.2 +/- 4.8 ml/min/100 g for post-ACZ (CVR of 33.9 +/- 13.2%). Task-related gCBF change was significantly related to memory score, performance on the Trail Making Test B (Trails-B), premorbid IQ, and education, and differed significantly between the learning-based groups. CONCLUSIONS: Cognitive reserve appears analogous to cardiac reserve. The ability to alter gCBF paralleled performance on general cognitive measures, was enhanced in higher levels of cognitive reserve, and was impaired in individuals who no longer appear to benefit from repeated exposure to testing.


Subject(s)
Acetazolamide/therapeutic use , Cerebellum/blood supply , Cognition , Memory Disorders/blood , Positron-Emission Tomography/methods , Aged , Behavior , Cerebrovascular Circulation , Female , Humans , Male , Memory Disorders/epidemiology , Memory Disorders/physiopathology , Retrospective Studies , Verbal Learning/drug effects
20.
J Neuropsychiatry Clin Neurosci ; 18(2): 178-85, 2006.
Article in English | MEDLINE | ID: mdl-16720794

ABSTRACT

Cerebral blood flow (CBF) was assessed during a verbal recall task using [(15)O]water positron emission tomography (PET) in older adults with mild cognitive deficits participating in a placebo-controlled donepezil trial. The placebo group demonstrated reduced CBF in the left frontal and temporal regions over the 6-month period, while those receiving donepezil did not. The placebo group's performance did not change on a list-learning task, while the donepezil group's performance improved, despite having had lower performance at intake. These findings suggest that donepezil treatment may be associated with a relative maintenance of CBF and improved list-learning.


Subject(s)
Brain/blood supply , Cognition Disorders/diagnostic imaging , Cognition Disorders/drug therapy , Indans/therapeutic use , Nootropic Agents/therapeutic use , Piperidines/therapeutic use , Positron-Emission Tomography , Activities of Daily Living/classification , Aged , Aged, 80 and over , Blood Flow Velocity/drug effects , Brain/diagnostic imaging , Cerebral Cortex/blood supply , Cerebral Cortex/diagnostic imaging , Dominance, Cerebral/physiology , Donepezil , Double-Blind Method , Female , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Mental Status Schedule , Middle Aged , Neuropsychological Tests , Regional Blood Flow/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...